Cai Lay Veterinary Pharmaceutical JSC

Cai Lay Veterinary Pharmaceutical JSC

HHNX:MKV
13,100.00
VND
-1,400.00
(-9.66%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Tai Van Do
Full Time Employees
116
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Tien Giang Vietnam
IPO Date
Nov 21, 2008
Business
Cai Lay Veterinary Pharmaceutical Joint Stock Company (MEKOVET) is a Vietnam-based company primarily engaged in the research, development, manufacturing, and distribution of veterinary pharmaceuticals, aquaculture health products, and animal feed supplements. Founded in 1990 as Cai Lay Livestock and Veterinary Pharmacy Company and equitized as a joint stock company in 2003, the company is headquartered in Cai Lay, Tien Giang Province, Vietnam, and is listed on the Hanoi Stock Exchange under the ticker symbol MKV. The company operates WHO-GMP certified manufacturing facilities to produce a comprehensive portfolio of animal healthcare solutions for swine, cattle, poultry, aquaculture species such as shrimp and fish, and companion animals. Its primary product lines encompass veterinary antibacterial medications and antibiotics, including injectable solutions and water-soluble powders such as MKV-Florfenicol 50, MKV-Amox 50, Enrocin, and Tiamulin; nutritional additives, vitamins, and mineral premixes designed to support animal vitality and growth performance; specialized aquaculture healthcare and water-treatment products, including Calcimix and Cevimix 10%; internal and external antiparasitic formulations; environmental disinfectants and biosecurity antiseptics, including Antisep spray; and companion animal hygiene products, such as Antipara shampoo and Super shampoo. MEKOVET serves livestock enterprises, commercial farmers, aquaculture operators, and pet owners through an extensive domestic distribution network of more than 200 authorized distributors and agents across Vietnam, alongside regional trade channels in Indochina. In recent corporate developments, MEKOVET entered into a major strategic alliance with Central Veterinary Medicine Joint Stock Company No. 1 (Vinavetco), with the backing of strategic shareholder Mavin Group, to form the Vietnam Veterinary Pharmaceutical Group. This consolidation integrates Vinavetco's veterinary vaccine and pharmaceutical footprint in Northern Vietnam with MEKOVET's modern manufacturing infrastructure and market presence across Southern Vietnam, creating a unified nationwide veterinary enterprise. Additionally, the company has continued to upgrade automated production lines at its Tien Giang manufacturing plant and expand its portfolio of targeted biosecurity, disease-prevention, and aquaculture treatment formulations to serve high-density commercial livestock and aquatic farming sectors.